What is Avalyn Pharma Inc. Common Stock?
operates as a clinical-stage biopharmaceutical company developing inhaled medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
operates as a clinical-stage biopharmaceutical company developing inhaled medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases. The company provides inhaled formulations of oral medicines directly to the lungs. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 1.26B.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.
| Shares sold | Shares bought | |
|---|---|---|
| 0-3months | 18322,429 shares $9.3M | 0 |
| 3-6months | 0 | 0 |
| 6-9months | 0 | 2555,555 shares $10.0M |
| 9-12months | 0 | 0 |